CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 2,113.10
-24.00 (-1.12%)
At close: Aug 17, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 129.24 billion as of August 17, 2026.
Market Cap
129.24B
Enterprise Value
130.60B
Revenue
14.79B
Ranking
n/a
PE Ratio
64.92
Stock Price
2,113.10
ChartMarket Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 129.24B, an increase of 46.91%. That is a compound annual growth rate of 77.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 129.24B | 52.58% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 268.01B |
| Granules India | 212.63B |
| AstraZeneca Pharma India | 193.84B |
| Caplin Point Laboratories | 188.55B |
| Jubilant Pharmova | 136.92B |
| Viyash Scientific | 111.56B |
| Procter & Gamble Health | 98.50B |
| Sanofi India | 74.77B |